Augmentation of therapy for combined loss of heterozygosity 1p and 16q in favorable histology wilms tumor: A Children's Oncology Group AREN0532 and AREN0533 study report

TY - JOUR

T1 - Augmentation of therapy for combined loss of heterozygosity 1p and 16q in favorable histology wilms tumor

T2 - A Children's Oncology Group AREN0532 and AREN0533 study report

AU - behalf of the AREN0532 and AREN0533 study committees.

AU - Dix, David B.

AU - Fernandez, Conrad V.

AU - Chi, Yueh Yun

AU - Mullen, Elizabeth A.

AU - Geller, James I.

AU - Gratias, Eric J.

AU - Khanna, Geetika

AU - Kalapurakal, John A.

AU - Perlman, Elizabeth J.

AU - Seibel, Nita L.

AU - Ehrlich, Peter F.

AU - Malogolowkin, Marcio

AU - Anderson, James

AU - Gastier-Foster, Julie

AU - Shamberger, Robert C.

AU - Kim, Yeonil

AU - Grundy, Paul E.

AU - Dome, Jeffrey S.

N1 - Publisher Copyright: © 2019 by American Society of Clinical Oncology

PY - 2019

Y1 - 2019

UR - http://www.scopus.com/inward/record.url?scp=85073183081&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85073183081&partnerID=8YFLogxK

U2 - 10.1200/JCO.18.01972

DO - 10.1200/JCO.18.01972

M3 - Article

C2 - 31449468

AN - SCOPUS:85073183081

SN - 0732-183X

VL - 37

SP - 2769

EP - 2777

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 30

ER -